Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-10-17
1993-02-23
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530322, 514 23, 514 552, 536 187, 536 53, 536 552, A61K 3170
Patent
active
051890178
ABSTRACT:
Described are the use of hexopyranose compounds of the formula I ##STR1## for the prophylaxis and treatment of virus infections, and novel pharmaceutical preparations especially suitable for the use in accordance with the invention.
The substituents in formula I have the meanings given in the claims.
REFERENCES:
patent: 2436699 (1948-02-01), Rose
patent: 2447715 (1948-08-01), Rose
patent: 3663235 (1972-05-01), Menz et al.
patent: 4082735 (1978-04-01), Jones et al.
patent: 4082736 (1978-04-01), Jones et al.
patent: 4119714 (1978-10-01), Kny et al.
patent: 4235792 (1980-11-01), Hsia et al.
patent: 4254115 (1981-03-01), Davidson et al.
patent: 4323560 (1982-06-01), Baschang et al.
patent: 4372949 (1980-02-01), Kodama et al.
patent: 4377570 (1983-03-01), Durette et al.
patent: 4406890 (1983-09-01), Tarcsay et al.
patent: 4414204 (1983-12-01), Tarcsay et al.
patent: 4423038 (1983-12-01), Baschang et al.
patent: 4426330 (1984-01-01), Sears
patent: 4426525 (1984-01-01), Hozumi et al.
patent: 4493832 (1985-01-01), Teraji et al.
patent: 4534899 (1985-08-01), Sears
patent: 4548923 (1985-10-01), Hartmann et al.
The Merck manual of Diagnosis and Therapy, 5th ed., Pub. by Merck Sharp and Dohme Research Lab. (1987) pp. 158-186.
Stedman's Medical Dictionary, 23rd ed. 1976, p. 1554.
Lukas et al., Archives of Virology vol. 49 pp. 1-11 (1975).
Avery's Drug Treatment 3rd Ed. pp. 1230-1249 (1987).
Derwent Abstract of European 138558 (Apr. 1985).
Derwent Abstract of Japanese 52087221 (1977).
Journal of Immunological Methods vol. 65 pp. 295-306 (1983).
Chem. Abstr. 66:95388g (1967).
Chem. Abstr. 69:95890b (1968).
Chem. Abstr. 71:123473e (1969).
Lukas Bohumir
Schmidt-Ruppin Karl H.
Brown Johnnie R.
Ciba-Geigy Corporation
Fishman Irving M.
Kaiser Karen G.
Peselev Elli
LandOfFree
Use of sugar derivatives for the prophylaxis and treatment of vi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of sugar derivatives for the prophylaxis and treatment of vi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of sugar derivatives for the prophylaxis and treatment of vi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2204819